Christian Girard is the co-founder of The PRV Fund, an initiative focused on providing non-dilutive funding to early-stage biotech companies developing treatments for tropical and rare pediatric-onset disorders, as well as medical countermeasures. Christian has a 30+ year professional background marked by his commitment to advancing rare pediatric disease drug development, from lab bench to approval. His involvement in this sector highlights his dedication to supporting innovative therapies aimed at improving the lives of children with rare diseases​. He is a graduate of ESCP Europe, an European business school. In his spare time, Christian likes tasting wines, Italian and Korean cuisine, as well as attending America’s Cup regattas.